» Articles » PMID: 31404974

Antimicrobial Silver Nanoparticles for Wound Healing Application: Progress and Future Trends

Overview
Publisher MDPI
Date 2019 Aug 14
PMID 31404974
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

Recent data have reported that the burden of infections related to antibiotic-resistant bacteria in the European Union and European Economic Area (EEA) can be estimated as the cumulative burden of tuberculosis, influenza, and human immunodeficiency virus (HIV). In wound management, the control of infections represents a crucial issue and a multi-billion dollar industry worldwide. For diabetic wounds ulcers, in particular, infections are related to the majority of amputations in diabetic patients, which today represent an increasing number of the elderly. The greatest barrier to healing is represented by the biofilm, an organized consortium of bacteria encapsulated in a self-produced extracellular polymeric substance with high resistance to conventional antimicrobial therapies. There is an urgent need for novel anti-biofilm strategies and novel antimicrobial agents and, in this scenario, silver nanotechnology has received tremendous attention in recent years in therapeutically enhanced healthcare. Due to its intrinsic therapeutic properties and the broad-spectrum antimicrobial efficacy, silver nanoparticles have opened new horizons towards novel approaches in the control of infections in wound healing. This review aims at providing the reader with an overview of the most recent progress in silver nanotechnology, with a special focus on the role of silver in the wound healing process.

Citing Articles

Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts.

Almatroudi A Biology (Basel). 2025; 14(2).

PMID: 40001933 PMC: 11852148. DOI: 10.3390/biology14020165.


The legacy of endophytes for the formation of bioactive agents, pigments, biofertilizers, nanoparticles and bioremediation of environment.

Panwar A, Manna S, Sahini G, Kaushik V, Kumar M, Govarthanan M World J Microbiol Biotechnol. 2025; 41(2):52.

PMID: 39871057 DOI: 10.1007/s11274-025-04265-2.


Nanoparticle-Doped Antibacterial and Antifungal Coatings.

Thapliyal D, Verros G, Arya R Polymers (Basel). 2025; 17(2).

PMID: 39861318 PMC: 11768809. DOI: 10.3390/polym17020247.


Natural Protein Films from Textile Waste for Wound Healing and Wound Dressing Applications.

Ottaviano L, Buoso S, Zamboni R, Sotgiu G, Posati T J Funct Biomater. 2025; 16(1).

PMID: 39852576 PMC: 11766051. DOI: 10.3390/jfb16010020.


Evaluation of the antibacterial properties of four bioactive biomaterials for chronic wound management.

Fakher S, Westenberg D Future Microbiol. 2025; 20(3):247-258.

PMID: 39810612 PMC: 11812403. DOI: 10.1080/17460913.2025.2453334.


References
1.
Tian J, Wong K, Ho C, Lok C, Yu W, Che C . Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem. 2006; 2(1):129-36. DOI: 10.1002/cmdc.200600171. View

2.
Li J, Chen J, Kirsner R . Pathophysiology of acute wound healing. Clin Dermatol. 2007; 25(1):9-18. DOI: 10.1016/j.clindermatol.2006.09.007. View

3.
Posnett J, Franks P . The burden of chronic wounds in the UK. Nurs Times. 2008; 104(3):44-5. View

4.
Shaw T, Martin P . Wound repair at a glance. J Cell Sci. 2009; 122(Pt 18):3209-13. PMC: 2736861. DOI: 10.1242/jcs.031187. View

5.
Michaels J, Campbell B, King B, Palfreyman S, Shackley P, Stevenson M . Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial). Br J Surg. 2009; 96(10):1147-56. DOI: 10.1002/bjs.6786. View